- Pharmacopeia to cut 40% of its workforce that it is eliminating 64 positions as a part of its restructuring programming. Most of the eliminated employees are expected to leave in October. However the CEO of Pharmacopeia said that it would allow them to focus better on strategic initiatives.
- Acadia would reduce its workforce about half (50%) to 65 employees as a part of their strategic restructuring. The source said the company would focus its efforts on its four most advanced drug including pimavanserin (Phase III, Parkinson's disease psychosis) and it would continue the partnership with Allergen for glaucoma(Phase I).Acadia added that it will significantly decrease spending on its earlier-stage programmes.
- Pfizer reported Wednesday that it will close its manufacturing plant in Little Island, Ireland, and that 180 jobs will be cut as a result. The move comes after the drugmaker failed to find a buyer for the facility. The plant is expected to close by the end of 2009.
What would be the major reason for this retrenchment and close down?
May it affect other pharmaceuticals also?
Will it affect CROs?
Let the discussion starts...
No comments:
Post a Comment